153 related articles for article (PubMed ID: 36297665)
1. Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with
Ferretti A; Simeoli R; Cairoli S; Pietrafusa N; Trivisano M; Dionisi Vici C; Specchio N; Goffredo BM
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297665
[TBL] [Abstract][Full Text] [Related]
2. Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy.
Kravetz MC; Viola MS; Prenz J; Curi M; Bramuglia GF; Tenembaum S
Front Pharmacol; 2021; 12():648519. PubMed ID: 34122071
[No Abstract] [Full Text] [Related]
3. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
[TBL] [Abstract][Full Text] [Related]
4. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
[TBL] [Abstract][Full Text] [Related]
5. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.
Takase C; Shirai K; Matsumura Y; Watanabe T; Watanabe A; Hirasawa-Inoue A; Mizuguchi T; Matsumoto N; Sugai K; Hayashi M
Brain Dev; 2020 Sep; 42(8):607-611. PubMed ID: 32505479
[TBL] [Abstract][Full Text] [Related]
6. Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations.
Yoshitomi S; Takahashi Y; Yamaguchi T; Oboshi T; Horino A; Ikeda H; Imai K; Okanishi T; Nakashima M; Saitsu H; Matsumoto N; Yoshimoto J; Fujita T; Ishii A; Hirose S; Inoue Y
Epileptic Disord; 2019 Feb; 21(1):48-54. PubMed ID: 30782581
[TBL] [Abstract][Full Text] [Related]
7. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
Borlot F; Abushama A; Morrison-Levy N; Jain P; Puthenveettil Vinayan K; Abukhalid M; Aldhalaan HM; Almuzaini HS; Gulati S; Hershkovitz T; Konanki R; Lingappa L; Luat AF; Shafi S; Tabarki B; Thomas M; Yoganathan S; Alfadhel M; Arya R; Donner EJ; Ehaideb SN; Gowda VK; Jain V; Madaan P; Myers KA; Otsubo H; Panda P; Sahu JK; Sampaio LPB; Sharma S; Simard-Tremblay E; Zak M; Whitney R
Epilepsia; 2020 Apr; 61(4):679-692. PubMed ID: 32167590
[TBL] [Abstract][Full Text] [Related]
8. Lack of response to quinidine in KCNT1-related neonatal epilepsy.
Numis AL; Nair U; Datta AN; Sands TT; Oldham MS; Patel A; Li M; Gazina E; Petrou S; Cilio MR
Epilepsia; 2018 Oct; 59(10):1889-1898. PubMed ID: 30182418
[TBL] [Abstract][Full Text] [Related]
9. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide.
Datta AN; Michoulas A; Guella I; ; Demos M
J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268
[No Abstract] [Full Text] [Related]
10. Antisense oligonucleotide therapy for KCNT1 encephalopathy.
Burbano LE; Li M; Jancovski N; Jafar-Nejad P; Richards K; Sedo A; Soriano A; Rollo B; Jia L; Gazina EV; Piltz S; Adikusuma F; Thomas PQ; Kopsidas H; Rigo F; Reid CA; Maljevic S; Petrou S
JCI Insight; 2022 Dec; 7(23):. PubMed ID: 36173683
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular characterization of
McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
[TBL] [Abstract][Full Text] [Related]
12. Two South Indian Children with KCNT1-Related Malignant Migrating Focal Seizures of Infancy - Clinical Characteristics and Outcome of Targeted Treatment with Quinidine.
Patil AA; Vinayan KP; Roy AG
Ann Indian Acad Neurol; 2019; 22(3):311-315. PubMed ID: 31359944
[No Abstract] [Full Text] [Related]
13. New use for an old drug: quinidine in KCNT1-related epilepsy therapy.
Liu R; Sun L; Wang Y; Wang Q; Wu J
Neurol Sci; 2023 Apr; 44(4):1201-1206. PubMed ID: 36437393
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Aicardi-Goutières syndrome and
Møller RS; Zhao L; Shoaff JR; Duno M; Andersen BN; Nguyen V; Fang TC; Kupelian V; Thorén R
Mol Genet Metab Rep; 2022 Dec; 33():100924. PubMed ID: 36262748
[TBL] [Abstract][Full Text] [Related]
15. KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.
Kuchenbuch M; Barcia G; Chemaly N; Carme E; Roubertie A; Gibaud M; Van Bogaert P; de Saint Martin A; Hirsch E; Dubois F; Sarret C; Nguyen The Tich S; Laroche C; des Portes V; Billette de Villemeur T; Barthez MA; Auvin S; Bahi-Buisson N; Desguerre I; Kaminska A; Benquet P; Nabbout R
Brain; 2019 Oct; 142(10):2996-3008. PubMed ID: 31532509
[TBL] [Abstract][Full Text] [Related]
16. Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature.
Abdelnour E; Gallentine W; McDonald M; Sachdev M; Jiang YH; Mikati MA
Seizure; 2018 Feb; 55():1-3. PubMed ID: 29291456
[TBL] [Abstract][Full Text] [Related]
17. Potassium Channel Subfamily T Member 1(KCNT1) Pathological Variant Causing Epilepsy Of Infancy With Migrating Focal Seizures: A Case Report.
Chand P; Angez M; Hameed AN; Kirmani S
J Pak Med Assoc; 2023 Aug; 73(8):1720-1722. PubMed ID: 37697770
[TBL] [Abstract][Full Text] [Related]
18. Targeting K
Cole BA; Clapcote SJ; Muench SP; Lippiat JD
Trends Pharmacol Sci; 2021 Aug; 42(8):700-713. PubMed ID: 34074526
[TBL] [Abstract][Full Text] [Related]
19. Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability.
Barcia G; Chemaly N; Kuchenbuch M; Eisermann M; Gobin-Limballe S; Ciorna V; Macaya A; Lambert L; Dubois F; Doummar D; Billette de Villemeur T; Villeneuve N; Barthez MA; Nava C; Boddaert N; Kaminska A; Bahi-Buisson N; Milh M; Auvin S; Bonnefont JP; Nabbout R
Neurol Genet; 2019 Dec; 5(6):e363. PubMed ID: 31872048
[TBL] [Abstract][Full Text] [Related]
20. Treatment Responsiveness in KCNT1-Related Epilepsy.
Fitzgerald MP; Fiannacca M; Smith DM; Gertler TS; Gunning B; Syrbe S; Verbeek N; Stamberger H; Weckhuysen S; Ceulemans B; Schoonjans AS; Rossi M; Demarquay G; Lesca G; Olofsson K; Koolen DA; Hornemann F; Baulac S; Rubboli G; Minks KQ; Lee B; Helbig I; Dlugos D; Møller RS; Bearden D
Neurotherapeutics; 2019 Jul; 16(3):848-857. PubMed ID: 31054119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
